EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Synthetic Platform for Antibody Junctional Diversification Beyond Natural Constraints

Wang Liu iD, Jun Yang, Yuhang Zhang, Xiaoli Xue

Advanced Science · 2026-11 · 13 (63)

DOI: 10.1002/advs.77339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.08.2026. Verfasst von Wang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Metabolism, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic…. Hauptthemen laut MEDLINE: Complementarity Determining Regions, Antibody Diversity, V(D)J Recombination, Protein Engineering. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project, and the Project of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody junctional diversity in jawed vertebrates arose from RAG transposon domestication, generating CDR3‐focused V(D)J recombination with lymphocyte specificity—a constrained system limiting engineered antibody diversity. To overcome these limitations, we developed ARESEC ( A ntibody R eprogram and E xpression S ystem in E ngineered C ells), a synthetic platform that enables programmable V(D)J recombination in non‐lymphoid HEK293T cells. Through engineered recombination signal sequences (RSS) and optimized RAG1/2 expression, ARESEC enables RSS‐guided DNA recombination across all three complementarity‐determining regions (CDR1/2/3). Co‐expression of terminal deoxynucleotidyl transferase (TdT) enhanced junctional sequence diversity by 41.5%–86.3% across 3 CDRs. The platform enables native IgG production by coupling mammalian surface display with FACS‐based functional screening. Using clinical‐grade antibodies (Nivolumab and Durvalumab) as high‐affinity starting scaffolds, we achieved further efficient affinity maturation through focused CDR diversification (library complexity >10 3 ). From these diversification libraries, we identified optimized variants including the anti‐PD‐L1 Dur1 with 2.01‐fold enhanced binding, demonstrating the system's capacity for rapid antibody optimization from minimal diversity sampling. Collectively, ARESEC establishes a synthetic platform that transcends natural V(D)J constraints, generating multi‐CDR diversification in non‐lymphoid cells to enable rapid discovery of affinity‐matured antibodies, effectively bridging immune evolution with modern antibody engineering demands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complementarity Determining RegionsAntibody DiversityV(D)J RecombinationProtein EngineeringHumansHEK293 CellsAnimals

Stichwörter der Autor:innen

V(D)J recombinationantibody CDR1/2/3 engineeringantibody diversificationantibody junctional diversity

Substanzen

Complementarity Determining Regions

Autor:innen und Institutionen

  • State Key Laboratory of Microbial Metabolism, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

ORCID-Profile: Wang Liu

Förderung

  • National Key Research and Development Program of China
  • Shanghai Municipal Science and Technology Major Project, and the Project of State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University

Zitieren

APA

Liu, W., Yang, J., Zhang, Y., & Xue, X. (2026). A Synthetic Platform for Antibody Junctional Diversification Beyond Natural Constraints. Advanced Science, 13(63). https://doi.org/10.1002/advs.77339

Vancouver

Liu W, Yang J, Zhang Y, Xue X. A Synthetic Platform for Antibody Junctional Diversification Beyond Natural Constraints. Advanced Science. 2026;13(63). doi:10.1002/advs.77339

BibTeX
@article{Liu2026,
  author = {Liu, Wang and Yang, Jun and Zhang, Yuhang and Xue, Xiaoli},
  title = {A Synthetic Platform for Antibody Junctional Diversification Beyond Natural Constraints},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {63},
  doi = {10.1002/advs.77339}
}
Kostenlos starten →